Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like American Control Electronics introduces CMC Series of standalone accessory card October 7, 2019 SBI’s Arundhati Bhattacharya served breach of privilege notice over farm loan waiver comment March 17, 2017 Axiomtek introduces IPC964- 512-F industrial embedded PC April 4, 2018
SBI’s Arundhati Bhattacharya served breach of privilege notice over farm loan waiver comment March 17, 2017